Delivery Order SPE2DB22D2206-SPE2DB23FGV69
Award Date
4/21/23
Potential Completion Date
4/24/23
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $83,424.00, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, and has an ultimate completion date of January 21, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $2,869.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, to support federal government healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.68, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,053.00 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product used in healthcare settings. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Visipaque 320 mg/ml bottle 100ml. The contract, valued at $2,990.80, was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 19, 2023. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA. This IDC, valued at up to $999,999,999.00, serves as a...
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed price delivery order for the supply of VISIPAQUE 320 MG/ML, a pharmaceutical product, with a ceiling value of $2,795.85 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,758.93 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 29, 2023 and was awarded on December 28, 2022. Amerisourcebergen Drug Corp holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,118.34 firm fixed price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December...
This is a $13,839.57 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance through January 31, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $2,089.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML medical supplies. The contract has a period of performance through January 18, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains...